Clopidogrel Camsylate

氯吡格雷樟脑磺酸盐

Report date: 2022/08/29 20:00:24
NME

Base Information

Drug NameClopidogrel Camsylate
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurinergic receptor P2Y12 antagonists
TargetsPurinergic receptor P2Y12
Therapy Area/IndicationsThrombosis
Global Approved IndicationsThrombosis
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2011/03/01
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKyungdong Pharmaceutical Corp
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsThrombosis
Inactive IndicationsN/A

Other Information

ATC CodeB01AC04
Related LinksN/A